PetIQ (NASDAQ:PETQ) – William Blair dropped their Q1 2018 EPS estimates for shares of PetIQ in a report released on Tuesday, April 3rd. William Blair analyst J. Andersen now forecasts that the company will post earnings per share of $0.02 for the quarter, down from their previous forecast of $0.24. William Blair also issued estimates for PetIQ’s FY2018 earnings at $0.68 EPS.
Several other brokerages also recently weighed in on PETQ. Zacks Investment Research downgraded PetIQ from a “buy” rating to a “hold” rating in a research report on Tuesday, March 27th. BidaskClub lowered shares of PetIQ from a “buy” rating to a “hold” rating in a research note on Wednesday, February 14th. Finally, Jefferies Group reissued a “buy” rating and set a $27.00 target price on shares of PetIQ in a research note on Monday, January 8th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and six have assigned a buy rating to the company. PetIQ currently has an average rating of “Buy” and a consensus target price of $27.50.
Shares of PETQ opened at $23.23 on Thursday. The stock has a market cap of $582.20 and a price-to-earnings ratio of 59.56. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.56 and a current ratio of 5.99. PetIQ has a fifty-two week low of $17.03 and a fifty-two week high of $28.23.
In other news, CEO Mccord Christensen sold 20,000 shares of the stock in a transaction dated Monday, April 2nd. The shares were sold at an average price of $26.22, for a total transaction of $524,400.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO John Newland sold 5,500 shares of the stock in a transaction dated Monday, March 19th. The stock was sold at an average price of $24.83, for a total transaction of $136,565.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 65,500 shares of company stock worth $1,657,765.
Several hedge funds have recently bought and sold shares of PETQ. New York State Common Retirement Fund purchased a new stake in shares of PetIQ during the 3rd quarter worth about $448,000. Bank of New York Mellon Corp purchased a new position in PetIQ in the 3rd quarter valued at about $1,200,000. Russell Investments Group Ltd. purchased a new position in PetIQ in the 3rd quarter valued at about $520,000. American International Group Inc. purchased a new position in PetIQ in the 3rd quarter valued at about $131,000. Finally, Wells Fargo & Company MN purchased a new position in PetIQ in the 3rd quarter valued at about $204,000. 37.02% of the stock is currently owned by institutional investors and hedge funds.
WARNING: “Q1 2018 Earnings Forecast for PetIQ Issued By William Blair (PETQ)” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/04/07/q1-2018-earnings-forecast-for-petiq-issued-by-william-blair-petq.html.
PetIQ Company Profile
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.